Essential Drugs in Brief No. 005 - 2001
(2001; 4 pages) View the PDF document
Table of Contents
View the documentTRIPS Workshop for the WHO African Region
Open this folder and view contentsAFRICAN REGION
Open this folder and view contentsREGION OF THE AMERICAS
Close this folderEASTERN MEDITERRANEAN REGION
View the documentPromoting Rational Drug Use - first course in Tehran
View the documentMeeting of the Regional Advisory Panel on Nursing and Consultation on Advanced Nursing Practice and Nurse Prescribing
Open this folder and view contentsEUROPEAN REGION
Open this folder and view contentsSOUTH-EAST ASIA REGION
Open this folder and view contentsWESTERN PACIFIC REGION
 

Meeting of the Regional Advisory Panel on Nursing and Consultation on Advanced Nursing Practice and Nurse Prescribing

BHURBAN, PAKISTAN, JUNE 2001.

The meeting, attended by 22 participants, from Bahrain, Cyprus, Iran, Iraq, Jordan, Lebanon, Oman, Pakistan, Saudi Arabia, Sudan, the United Arab Emirates and Yemen was the first joint meeting to be held between representatives of the disciplines of nursing, medicine and pharmacy in the Region.

The objectives were to:

• identify the factors and issues creating the need for nurse prescribing;

• develop a regional policy framework for nurse prescribing to assist Member States; and

• develop a mechanism to strengthen the collection of evidence and information for nurse prescribing.

The meeting concluded that quality health care services, including prescribing of an appropriate range of essential drugs, at the first level of the health care system, should be available to health service clients. In many settings, nurses are the backbone of the primary health care system, and as such should be authorized and able to prescribe within the scope of nursing practice. Specific recommendations to WHO included:

• assistance to Member States in their efforts to identify, formalize and strengthen the roles and responsibilities of all health care providers involved in prescribing, with an emphasis on rational use of drugs;

• initiation and coordination of demonstration projects and case studies to evaluate the impact and cost-effectiveness of using different categories of health care providers, with special emphasis on nurses, in prescribing and rational use of drugs.

 

to previous section to next section
 

Last updated: May 3, 2013